Empowered Funds LLC Has $10.25 Million Stake in Select Medical Holdings Corporation $SEM

Key Points

• Empowered Funds LLC increased its stake in Select Medical Holdings Corporation by 96.0% during the 1st quarter, now owning 613,801 shares worth approximately $10.25 million.
• Select Medical reported $0.32 earnings per share for the latest quarter, surpassing expectations, with a revenue of $1.34 billion for the period.
• The stock has a current market cap of $1.60 billion and is down 2.4% recently, with a consensus average target price of $20.25 from analysts.

Empowered Funds LLC increased its position in shares of Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 96.0% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 613,801 shares of the health services provider's stock after buying an additional 300,631 shares during the period. Empowered Funds LLC owned 0.48% of Select Medical worth $10,250,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in SEM. Bank of America Corp DE increased its holdings in Select Medical by 46.7% during the fourth quarter. Bank of America Corp DE now owns 1,192,578 shares of the health services provider's stock worth $22,480,000 after buying an additional 379,598 shares during the last quarter. Deutsche Bank AG increased its holdings in shares of Select Medical by 47.4% in the fourth quarter. Deutsche Bank AG now owns 93,316 shares of the health services provider's stock valued at $1,759,000 after purchasing an additional 30,023 shares during the last quarter. D. E. Shaw & Co. Inc. increased its holdings in shares of Select Medical by 5.3% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 49,330 shares of the health services provider's stock valued at $930,000 after purchasing an additional 2,469 shares during the last quarter. Graham Capital Management L.P. acquired a new position in shares of Select Medical in the fourth quarter valued at $1,125,000. Finally, Lazard Asset Management LLC increased its holdings in shares of Select Medical by 47.8% in the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock valued at $130,000 after purchasing an additional 2,255 shares during the last quarter. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have commented on SEM. UBS Group reiterated a "neutral" rating and issued a $14.00 price objective (down from $15.00) on shares of Select Medical in a report on Monday, August 4th. Bank of America decreased their price objective on shares of Select Medical from $18.00 to $15.00 and set a "buy" rating on the stock in a report on Wednesday. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Select Medical currently has a consensus rating of "Moderate Buy" and an average price target of $19.20.

Select Medical Stock Performance

Shares of SEM stock traded down $0.28 on Friday, hitting $12.53. The company's stock had a trading volume of 489,877 shares, compared to its average volume of 857,438. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.15 and a current ratio of 1.15. The stock's 50 day moving average is $13.41 and its 200-day moving average is $15.12. Select Medical Holdings Corporation has a fifty-two week low of $11.65 and a fifty-two week high of $40.98. The company has a market capitalization of $1.55 billion, a PE ratio of 11.82, a PEG ratio of 0.52 and a beta of 1.25.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, beating the consensus estimate of $0.28 by $0.04. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The business had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.35 billion. During the same period in the prior year, the company posted $0.60 earnings per share. Select Medical's revenue was up 4.5% compared to the same quarter last year. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Equities research analysts expect that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Wednesday, August 13th were paid a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date was Wednesday, August 13th. Select Medical's dividend payout ratio is presently 23.58%.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.